Dyazide and Seborrhoeic dermatitis - a phase IV clinical study of FDA data

Summary:

Seborrhoeic dermatitis is reported as a side effect among people who take Dyazide (hydrochlorothiazide; triamterene), especially for people who are male, 60+ old, also take Thalidomide, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Seborrhoeic dermatitis when taking Dyazide. It is created by eHealthMe based on reports of 11,105 people who have side effects when taking Dyazide from the FDA, and is updated regularly.

What is Dyazide?

Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 11,506 Dyazide users. Check the latest studies of Dyazide.

What is Seborrhoeic dermatitis?

Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp) is found to be associated with 362 drugs and 513 conditions by eHealthMe. Check the latest studies of Seborrhoeic dermatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

11,105 people reported to have side effects when taking Dyazide.
Among them, 32 people (0.29%) have Seborrhoeic dermatitis.

Could Dyazide cause Seborrhoeic dermatitis?

Among these 32 people:

What is the gender of people who have Seborrhoeic dermatitis when taking Dyazide? *

female: 6.25 %
male: 93.75 %

What is the age of people who have Seborrhoeic dermatitis when taking Dyazide? *

What are other drugs people take besides Dyazide? *

What are other side effects people have besides Seborrhoeic dermatitis? *

Aortic Valve Incompetence: 30 people, 93.75%
High Blood Cholesterol: 29 people, 90.62%
Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 29 people, 90.62%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 29 people, 90.62%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 29 people, 90.62%
Renal Impairment (severely reduced kidney function): 29 people, 90.62%
Hallucinations (sensations that appear real but are created by your mind): 29 people, 90.62%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 29 people, 90.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 29 people, 90.62%
Fainting (loss of consciousness and postural tone): 29 people, 90.62%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 29 people, 90.62%
Mood Swings (an extreme or rapid change in mood): 25 people, 78.12%
Joint Pain: 25 people, 78.12%
High Blood Cholesterol: 25 people, 78.12%
Diarrhea: 25 people, 78.12%
Seasonal Allergy (allergic condition due to certain season): 18 people, 56.25%
Blood Triglycerides Decreased: 18 people, 56.25%
Rashes (redness): 1 person, 3.12%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 3.12%
Indigestion: 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Dyazide and have Seborrhoeic dermatitis?

- Check whether Seborrhoeic dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dyazide:

Dyazide (11,506 reports)

Seborrhoeic dermatitis treatments and more:

Seborrhoeic dermatitis (3,282 reports)

How severe was Seborrhoeic dermatitis and when was it recovered:

Seborrhoeic dermatitis in Dyazide

Expand to all the drugs that have ingredients of hydrochlorothiazide; triamterene:

Seborrhoeic dermatitis and drugs with ingredients of hydrochlorothiazide; triamterene

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dyazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (362 drugs)

Browse all the conditions that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; triamterene (the active ingredients of Dyazide) and Dyazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.